| Premier Family Medicine, Llc | |
|
747 E County Line Rd Ste B Greenwood IN 46143-1082 | |
| (317) 789-9600 | |
| (317) 789-0600 |
| Full Name | Premier Family Medicine, Llc |
|---|---|
| Speciality | Family Medicine |
| Location | 747 E County Line Rd Ste B, Greenwood, Indiana |
| Authorized Official Name and Position | Michael E Yoder (MANAGING PARTNER) |
| Authorized Official Contact | 3174727812 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Premier Family Medicine, Llc 747 E County Line Rd Ste B Greenwood IN 46143-1082 Ph: (317) 789-9600 | Premier Family Medicine, Llc 747 E County Line Rd Ste B Greenwood IN 46143-1082 Ph: (317) 789-9600 |
| NPI Number | 1093145427 |
|---|---|
| Provider Enumeration Date | 11/21/2013 |
| Last Update Date | 03/07/2018 |
| Medicare PECOS PAC ID | 9638308422 |
|---|---|
| Medicare Enrollment ID | O20140127000311 |
News Archive
Bayer HealthCare and Onyx Pharmaceuticals today announced that the U.S. Food and Drug Administration has granted Priority Review designation to the supplemental New Drug Application for the oral multi-kinase inhibitor Nexavar (sorafenib) tablets under evaluation for the treatment of locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer.
According to researchers, an average American gets 16% of calories from the sugar in their diet. These may be sugars added to processed foods during manufacture.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that researchers from the Mayo Clinic will be presenting data on the use of XOMA's high-affinity antibody to interleukin-1 beta (IL-1 beta), XOMA 052, in myeloma at the 101st Annual Meeting of the American Association of Cancer Research (AACR).
USDA's database of antioxidant values for various foods, places blueberry juice at the top of the list among more than a dozen juices tested including pomegranate, apple, prune, cranberry and Concord grape
TYRX, Inc. announced today that it has received U.S. Food and Drug Administration clearance for expanded indications in marketing the AIGISRx N Antibacterial Envelope for use with spinal cord neuromodulators.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093145427 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| Provider Name | Koshy Oommen |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1497844278 PECOS PAC ID: 3375528607 Enrollment ID: I20040622000077 |
News Archive
Bayer HealthCare and Onyx Pharmaceuticals today announced that the U.S. Food and Drug Administration has granted Priority Review designation to the supplemental New Drug Application for the oral multi-kinase inhibitor Nexavar (sorafenib) tablets under evaluation for the treatment of locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer.
According to researchers, an average American gets 16% of calories from the sugar in their diet. These may be sugars added to processed foods during manufacture.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that researchers from the Mayo Clinic will be presenting data on the use of XOMA's high-affinity antibody to interleukin-1 beta (IL-1 beta), XOMA 052, in myeloma at the 101st Annual Meeting of the American Association of Cancer Research (AACR).
USDA's database of antioxidant values for various foods, places blueberry juice at the top of the list among more than a dozen juices tested including pomegranate, apple, prune, cranberry and Concord grape
TYRX, Inc. announced today that it has received U.S. Food and Drug Administration clearance for expanded indications in marketing the AIGISRx N Antibacterial Envelope for use with spinal cord neuromodulators.
› Verified 6 days ago
| Provider Name | Mary C Yoder |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1346217312 PECOS PAC ID: 8527037837 Enrollment ID: I20041001000829 |
News Archive
Bayer HealthCare and Onyx Pharmaceuticals today announced that the U.S. Food and Drug Administration has granted Priority Review designation to the supplemental New Drug Application for the oral multi-kinase inhibitor Nexavar (sorafenib) tablets under evaluation for the treatment of locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer.
According to researchers, an average American gets 16% of calories from the sugar in their diet. These may be sugars added to processed foods during manufacture.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that researchers from the Mayo Clinic will be presenting data on the use of XOMA's high-affinity antibody to interleukin-1 beta (IL-1 beta), XOMA 052, in myeloma at the 101st Annual Meeting of the American Association of Cancer Research (AACR).
USDA's database of antioxidant values for various foods, places blueberry juice at the top of the list among more than a dozen juices tested including pomegranate, apple, prune, cranberry and Concord grape
TYRX, Inc. announced today that it has received U.S. Food and Drug Administration clearance for expanded indications in marketing the AIGISRx N Antibacterial Envelope for use with spinal cord neuromodulators.
› Verified 6 days ago
| Provider Name | Keith A Priddle |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1235676099 PECOS PAC ID: 0941560577 Enrollment ID: I20180130002317 |
News Archive
Bayer HealthCare and Onyx Pharmaceuticals today announced that the U.S. Food and Drug Administration has granted Priority Review designation to the supplemental New Drug Application for the oral multi-kinase inhibitor Nexavar (sorafenib) tablets under evaluation for the treatment of locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer.
According to researchers, an average American gets 16% of calories from the sugar in their diet. These may be sugars added to processed foods during manufacture.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that researchers from the Mayo Clinic will be presenting data on the use of XOMA's high-affinity antibody to interleukin-1 beta (IL-1 beta), XOMA 052, in myeloma at the 101st Annual Meeting of the American Association of Cancer Research (AACR).
USDA's database of antioxidant values for various foods, places blueberry juice at the top of the list among more than a dozen juices tested including pomegranate, apple, prune, cranberry and Concord grape
TYRX, Inc. announced today that it has received U.S. Food and Drug Administration clearance for expanded indications in marketing the AIGISRx N Antibacterial Envelope for use with spinal cord neuromodulators.
› Verified 6 days ago
News Archive
Bayer HealthCare and Onyx Pharmaceuticals today announced that the U.S. Food and Drug Administration has granted Priority Review designation to the supplemental New Drug Application for the oral multi-kinase inhibitor Nexavar (sorafenib) tablets under evaluation for the treatment of locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer.
According to researchers, an average American gets 16% of calories from the sugar in their diet. These may be sugars added to processed foods during manufacture.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that researchers from the Mayo Clinic will be presenting data on the use of XOMA's high-affinity antibody to interleukin-1 beta (IL-1 beta), XOMA 052, in myeloma at the 101st Annual Meeting of the American Association of Cancer Research (AACR).
USDA's database of antioxidant values for various foods, places blueberry juice at the top of the list among more than a dozen juices tested including pomegranate, apple, prune, cranberry and Concord grape
TYRX, Inc. announced today that it has received U.S. Food and Drug Administration clearance for expanded indications in marketing the AIGISRx N Antibacterial Envelope for use with spinal cord neuromodulators.
› Verified 6 days ago
Community Health Network Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2943 S Morgantown Rd, Greenwood, IN 46143 Phone: 317-882-1233 | |
County Line Medical Pavilion Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 333 E County Line Rd, Suite B, Greenwood, IN 46143 Phone: 317-497-6333 Fax: 317-497-6334 | |
Greenwood Group Health, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 549 E County Line Rd Ste D, Greenwood, IN 46143 Phone: 281-429-8526 | |
Greenwood Family Care A.s.a.p. Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1680 Stonegate Dr, Greenwood, IN 46142 Phone: 317-215-4367 Fax: 317-888-4706 | |
Southside Adult Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 45 N Madison Ave, Greenwood, IN 46142 Phone: 317-887-7624 Fax: 317-887-7625 | |
Iu Health Workplace Services Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2943 S Morgantown Rd, Greenwood, IN 46143 Phone: 317-882-1233 |